QIAGEN
QIAGEN provides technologies and products for preanalytical sample preparation and linked molecular assay solutions. QIAGEN also supplies diagnostic kits, tests, and assays for human and veterinary molecular diagnostics.QIAGEN offers its sample and assay consumable products in kit form.
QIAGEN
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
1986-01-01
Address:
Venlo, Limburg, The Netherlands
Country:
The Netherlands
Website Url:
http://www.qiagen.com
Total Employee:
1001+
Status:
Active
Contact:
+31 77 320 8400
Total Funding:
4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network Google Universal Analytics Font Awesome Domain Not Resolving
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Human Longevity
Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.
Illumina
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-05-11 | BLIRT | BLIRT acquired by Qiagen | N/A |
| 2020-09-17 | NeuMoDx Molecular | NeuMoDx Molecular acquired by Qiagen | 248 M USD |
| 2019-01-07 | N-of-One | N-of-One acquired by Qiagen | N/A |
| 2018-11-01 | Parsagen | Parsagen acquired by Qiagen | N/A |
| 2018-02-01 | STAT-Dx | STAT-Dx acquired by Qiagen | 191 M USD |
| 2017-01-09 | OmicSoft Corp. | OmicSoft Corp. acquired by Qiagen | N/A |
| 2015-11-01 | MO BIO Laboratories | MO BIO Laboratories acquired by Qiagen | N/A |
| 2014-06-05 | PrimeraDx (Primera Biosystems) | PrimeraDx (Primera Biosystems) acquired by Qiagen | N/A |
| 2014-05-21 | BIOBASE | BIOBASE acquired by Qiagen | N/A |
| 2013-10-25 | CLC bio | CLC bio acquired by Qiagen | N/A |
Investors List
U.S. Department of Health & Human Services
U.S. Department of Health & Human Services investment in Grant - Qiagen
U.S. Department of Defense
U.S. Department of Defense investment in Grant - Qiagen
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-01-19 | Glyphic Biotechnologies | Qiagen investment in Grant - Glyphic Biotechnologies | 40 K USD |
| 2021-07-01 | Actome | Qiagen investment in Seed Round - Actome | N/A |
| 2018-03-20 | ArcherDX | Qiagen investment in Series A - ArcherDX | 35 M USD |
| 2016-01-07 | Exosome Diagnostics | Qiagen investment in Series B - Exosome Diagnostics | 16 M USD |
| 2014-12-17 | Protagen | Qiagen investment in Venture Round - Protagen | 10 M EUR |
| 2014-03-11 | Exosome Diagnostics | Qiagen investment in Series B - Exosome Diagnostics | 27 M USD |
| 2013-01-08 | Drug Response Dx | Qiagen investment in Series A - Drug Response Dx | N/A |
| 2012-01-30 | Xagenic | Qiagen investment in Series A - Xagenic | 10 M USD |
| 1999-08-03 | Coley Pharmaceutical Group | Qiagen investment in Series B - Coley Pharmaceutical Group | 12.9 M USD |
| 1998-06-01 | Ingenium Pharmaceuticals AG | Qiagen investment in Seed Round - Ingenium Pharmaceuticals AG | N/A |
Newest Events participated
Key Employee Changes
| Date | New article |
|---|---|
| 2020-03-24 | QIAGEN Names Thierry Bernard as Chief Executive Officer |
Official Site Inspections
http://www.qiagen.com Semrush global rank: 146.6 K Semrush visits lastest month: 591.44 K
- Host name: 91.226.249.121
- IP address: 91.226.249.121
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
